FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204203225> ?p ?o ?g. }

• W3204203225 endingPage "100470" @default.
• W3204203225 startingPage "100470" @default.
• W3204203225 abstract "Rebiopsies characterizing resistance mutations in patients with non-small cell lung cancer (NSCLC) can guide personalized medicine and improve overall survival rates. In this systematic review, we examine the suitability of percutaneous core-needle biopsy (PT-CNB) to obtain adequate samples for molecular characterization of the acquired resistance mutation T790M. This review provides evidence that PT-CNB can obtain samples with high adequacy, with a mutation detection rate that is in accordance with prior literature.Non-small cell lung cancer (NSCLC) comprises 85% of all lung cancers and has seen improved survival rates with the rise of personalized medicine. Resistance mutations to first-line therapies, such as T790M, however, render first-line therapies ineffective. Rebiopsies characterizing resistance mutations inform therapeutic decisions, which result in prolonged survival. Given the high efficacy of percutaneous core-needle biopsy (PT-CNB), we conducted the first systematic review to analyze the ability of PT-CNB to obtain samples of high adequacy in order to characterize the acquired resistance mutation T790M in patients with NSCLC.We performed a comprehensive literature search across PubMed, Embase, and CENTRAL. Search terms related to NSCLC, rebiopsy, and PT-CNB were used to obtain results. We included all prospective and retrospective studies that satisfied our inclusion and exclusion criteria. A random effects model was utilized to pool adequacy and detection rates of the chosen articles. We performed a systematic review, meta-analysis, and meta-regression to investigate the adequacy and T790M detection rates of samples obtained via PT-CNB.Out of the 173 studies initially identified, 5 studies met the inclusion and exclusion criteria and were chosen for our final cohort of 436 patients for meta-analysis. The pooled adequacy rate of samples obtained via PT-CNB was 86.92% (95% CI: [79.31%, 92.0%]) and the pooled T790M detection rate was 46.0% (95% CI: [26.6%, 66.7%]). There was considerable heterogeneity among studies (I2 > 50%) in both adequacy and T790M detection rates.PT-CNB can obtain adequate samples for T790M molecular characterization in NSCLC lung cancer patients. Additional prospective studies are needed to corroborate the results in this review." @default.
• W3204203225 created "2021-10-11" @default.
• W3204203225 creator A5009410979 @default.
• W3204203225 creator A5016435517 @default.
• W3204203225 creator A5020694651 @default.
• W3204203225 creator A5031747877 @default.
• W3204203225 creator A5035137748 @default.
• W3204203225 creator A5046679240 @default.
• W3204203225 creator A5050238426 @default.
• W3204203225 creator A5053084467 @default.
• W3204203225 creator A5070717677 @default.
• W3204203225 creator A5080096770 @default.
• W3204203225 creator A5085518364 @default.
• W3204203225 date "2021-01-01" @default.
• W3204203225 modified "2023-10-01" @default.
• W3204203225 title "Adequacy of samples obtained via percutaneous core-needle rebiopsy for EGFR T790M molecular analysis in patients with non-small cell lung cancer following acquired resistance to first-line therapy: A systematic review and meta-analysis" @default.
• W3204203225 cites W1480161907 @default.
• W3204203225 cites W1970433797 @default.
• W3204203225 cites W2040875963 @default.
• W3204203225 cites W2076210779 @default.
• W3204203225 cites W2093613683 @default.
• W3204203225 cites W2107328434 @default.
• W3204203225 cites W2119721265 @default.
• W3204203225 cites W2122590064 @default.
• W3204203225 cites W2125435699 @default.
• W3204203225 cites W2137591261 @default.
• W3204203225 cites W2185481272 @default.
• W3204203225 cites W2328294134 @default.
• W3204203225 cites W2567467789 @default.
• W3204203225 cites W2574398598 @default.
• W3204203225 cites W2594615942 @default.
• W3204203225 cites W2744755223 @default.
• W3204203225 cites W2761717617 @default.
• W3204203225 cites W2762351050 @default.
• W3204203225 cites W2784730671 @default.
• W3204203225 cites W2790922923 @default.
• W3204203225 cites W2792049071 @default.
• W3204203225 cites W2792628494 @default.
• W3204203225 cites W2793850856 @default.
• W3204203225 cites W2883797791 @default.
• W3204203225 cites W2889101298 @default.
• W3204203225 cites W2906843719 @default.
• W3204203225 cites W2910873889 @default.
• W3204203225 cites W2911188335 @default.
• W3204203225 cites W2912107322 @default.
• W3204203225 cites W2915691873 @default.
• W3204203225 cites W2925148107 @default.
• W3204203225 cites W2936627868 @default.
• W3204203225 cites W2944874515 @default.
• W3204203225 cites W2945046785 @default.
• W3204203225 cites W2947943263 @default.
• W3204203225 cites W2953206814 @default.
• W3204203225 cites W2976278991 @default.
• W3204203225 cites W3033478934 @default.
• W3204203225 cites W3131416308 @default.
• W3204203225 cites W3137236253 @default.
• W3204203225 cites W3137667505 @default.
• W3204203225 cites W3138947996 @default.
• W3204203225 cites W3146142859 @default.
• W3204203225 cites W3159018336 @default.
• W3204203225 cites W3159127233 @default.
• W3204203225 cites W4240976793 @default.
• W3204203225 doi "https://doi.org/10.1016/j.ctarc.2021.100470" @default.
• W3204203225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34628209" @default.
• W3204203225 hasPublicationYear "2021" @default.
• W3204203225 type Work @default.
• W3204203225 sameAs 3204203225 @default.
• W3204203225 citedByCount "3" @default.
• W3204203225 countsByYear W32042032252022 @default.
• W3204203225 crossrefType "journal-article" @default.
• W3204203225 hasAuthorship W3204203225A5009410979 @default.
• W3204203225 hasAuthorship W3204203225A5016435517 @default.
• W3204203225 hasAuthorship W3204203225A5020694651 @default.
• W3204203225 hasAuthorship W3204203225A5031747877 @default.
• W3204203225 hasAuthorship W3204203225A5035137748 @default.
• W3204203225 hasAuthorship W3204203225A5046679240 @default.
• W3204203225 hasAuthorship W3204203225A5050238426 @default.
• W3204203225 hasAuthorship W3204203225A5053084467 @default.
• W3204203225 hasAuthorship W3204203225A5070717677 @default.
• W3204203225 hasAuthorship W3204203225A5080096770 @default.
• W3204203225 hasAuthorship W3204203225A5085518364 @default.
• W3204203225 hasBestOaLocation W32042032251 @default.
• W3204203225 hasConcept C121608353 @default.
• W3204203225 hasConcept C126322002 @default.
• W3204203225 hasConcept C143998085 @default.
• W3204203225 hasConcept C2776256026 @default.
• W3204203225 hasConcept C2777930144 @default.
• W3204203225 hasConcept C2781187634 @default.
• W3204203225 hasConcept C32220436 @default.
• W3204203225 hasConcept C526805850 @default.
• W3204203225 hasConcept C60644358 @default.
• W3204203225 hasConcept C71924100 @default.
• W3204203225 hasConcept C86803240 @default.
• W3204203225 hasConceptScore W3204203225C121608353 @default.
• W3204203225 hasConceptScore W3204203225C126322002 @default.
• W3204203225 hasConceptScore W3204203225C143998085 @default.
• W3204203225 hasConceptScore W3204203225C2776256026 @default.
• W3204203225 hasConceptScore W3204203225C2777930144 @default.

• next